Has Michael Alexiades, MD received payments from drug or device companies?

Yes. Drug and device makers reported $570,916 in general payments to Michael Alexiades, MD across 101 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Alexiades, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Alexiades, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Alexiades, MD

Orthopaedic Surgery · New York, NYNPI 1558467027

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (55.0%), other and consulting fees — rather than concentrated in one kind of arrangement. Encore Medical, LP accounts for 98.2% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2021 at $265,615 and has fallen 58.1% since, to $111,406 in 2025. Among orthopaedic surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$570,916in general payments, 2019–2025

Across 101 payments — averaging $5652.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Encore Medical, LP$560K
Medical Device Business Services, Inc.$7K
Intellijoint Surgical Inc.$3K
Zimmer Biomet$123

$15,979in research payments, 2019–2025

Across 8 payments — averaging $1997.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medical Device Business Services, Inc.$9K
Stryker$7K

$1,053in ownership & investment interests, 2019–2025

Across 8 payments — averaging $131.62 each. An ownership or investment interest held by the physician or an immediate family member.

Intellijoint Surgical Inc.$1K
Insight Medical Systems, Inc.$0
Shoulder Innovations, Inc.$0

What the payments were for

Royalty or licence$314,28755%
Consulting fees$48,6629%
Travel & lodging$6,7521%
Food & beverage$8050%
Other$200,41035%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Encore Medical, LP	91	$560,481
Medical Device Business Services, Inc.	4	$7,020
Intellijoint Surgical Inc.	5	$3,292
Zimmer Biomet	1	$123

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DJO SURGICAL$149,400
DJO Surgical Empowr Acetabular System$53,480
ACTIS$7,020
CORAIL$7,020
PINNACLE$7,020
DePuy Synthes Advantage$4,680
DJO Surgical FMP Acetabular System$4,165
DJO Surgical 3DKnee System$3,287
Intellijoint HIP$2,792
DJO Surgical Empowr Knee System$2,574
DJO Surgical TaperFill Hip System$1,300
DJO Surgical Linear Hip System$1,300
DJO Surgical CLP Hip System$1,026
Intellijoint$500
ROSA$123

How this compares

$570,916 in reported general payments places this provider in the 95th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024

$2,313

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Diclofenac Sodium-MisoprostolDiclofenac Sodium/Misoprostol	14	$1,287
Meloxicam	78	$255
Amoxicillin	80	$157

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in New York

Anthony RomeoNew York$26.8M
Lawrence LenkeNew York$26.8M
Edwin SuNew York$13.2M
William RicciNew York$11.6M
Steven HaasNew York$11.3M
Giles ScuderiNew York$10.7M
Joseph ZuckermanNew York$9.9M
Evan FlatowNew York$9.6M
Bradford ParsonsNew York$9.4M
Geoffrey WestrichNew York$7.1M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →